Dublin, July 14, 2017 -- The "High Throughput Flow Assay Trends" report has been added to Research and Markets' offering.
This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on high throughput flow cytometry (HT flow) screening carried out in January 2017.
The survey was initiated as part of the publisher's tracking of emerging life science marketplaces and to update the previous HT Flow Assay Trends report 2015.
The questionnaire was compiled to meet the needs, requirements and interests of the flow cytometry vendor community.
The objectives were to document the current implementation and use of HT flow assays in screening, and to understand future user requirements. The aim was to compile a reference document on HT flow assays, which could be compared directly relative to our previous 2015 report.
Equal emphasis was given to soliciting opinion from the large molecule, small molecule and immunoassay screening segments worldwide.
The survey looked at the following aspects of HT flow screening, as practiced today (2017) and in a few cases as predicted for the future (2019):
- Why respondents have enabled or why they are interested in HT flow
- How respondents have achieved HT flow analysis to date and typical throughput realised with current instrument approach
- Will implementation of HT flow mainly displace or complement existing screening technologies
- Key diseases/therapeutic areas targeted with HT flow screening
- Target classes most interested in applying HT flow assays
- Broad applications areas most using or most considering using HT flow assays
- Key applications for HT flow in respondent's research
- Main benefits of HT flow versus other techniques
- Plate processing time considered adequate for HT flow needs
- Preferred sample presentation/handling format for HT flow and the target sample (aspirate) volume
- Number of parameters to be multiplexed in cell-based HT flow assays
- Number of analytes to be multiplexed in bead-based HT flow assays
- Samples types to be analysed with HT flow
- Where cell markers of interest in HT flow screens are located
- Main cell labelling technique/source
- Type of endpoints of most interest in HT flow screens
- Intention to carry out any front end processing or sample preparation prior to HT flow
- Number of different primary screens and number of wells to be tested per screen for cell-based and bead-based HT flow assays
- Estimated cost per sample (microplate well) analysed using cell-based and bead-based HT flow assays
- Vendor that first comes to mind when thinking of flow cytometry in general and HT flow specifically
- Plans to purchase any instrumentation to enable HT flow assays
- Capex budget for HT flow detection instruments
- Reagents and consumables budget for HT flow assays
- How respondents have deployed HT flow instrumentation into their screening environment/core facility
- Biggest limitations (obstacles) in using HT flow assays today
- Ratings of possible limitations of HT flow
- Biggest hurdles in software and data analysis for HT flow
- Level of agreement with statements about the status of HT flow assays
- And any unmet needs in HT flow screening today.
For more information about this report visit https://www.researchandmarkets.com/research/n66f7q/high_throughput
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Laboratory Equipment


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 



